Amyloidosis News - July 2021

In patients with light chain amyloidosis and cardiac involvement, treatment with D-VCd resulted in higher rates of cardiac response, with possible improvement in fatigue-related variables. Read More ›

Preliminary findings suggest that diflunisal may be a cost-effective alternative for patients with transthyretin amyloid cardiomyopathy who may not be able to afford tafamidis. Read More ›

Plasma biomarkers may help differentiate TTR V142I carriers from noncarriers in young preclinical cases. Read More ›

This case study highlights the importance of careful evaluation when determining whether a patient has AL or ATTR cardiac amyloidosis. Read More ›

At the time of common orthopedic surgeries, amyloid deposition can be detected, especially in patients aged ≥70 years, providing clinicians with an opportunity for early diagnosis. Read More ›

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to receive: